Accordingly, studies suggest that proline metabolism, through proline dehydrogenase (PRODH) and proline dehydrogenase reductase (PYCR), is associated with breast cancer metastasis, being upregulated in metastases compared to primary breast cancer tumors (160, 161). Here, PRODH is linked to breast carcinoma.